The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes

Keyphrases

• Idiopathic Intracranial Hypertension Treatment Trial 100%
• Acetazolamide 83%
• Weight Loss 50%
• Idiopathic Intracranial Hypertension 50%
• Vision Loss 33%
• Quality of Life 33%
• Placebo Groups 16%
• Clinical Experience 16%
• Multicenter Trial 16%
• Effective Treatment 16%
• Treatment Group 16%
• Tolerability 16%
• Papilledema 16%
• Increased Intracranial Pressure 16%
• Hypertension Management 16%
• Treatment Protocol 16%
• Literature Search 16%
• PubMed Search 16%
• Expert Opinion 16%
• Optical Coherence Tomography 16%
• Fundus Photography 16%
• Randomized Prospective Trial 16%
• PubMed Literature 16%
• Safe Use 16%
• Cerebrospinal Fluid Opening Pressure 16%
• Background Prior 16%
• Provided Support 16%
• Study within a Trial 16%
• Visual Field Outcome 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Idiopathic Intracranial Hypertension 100%
• Acetazolamide 55%
• Visual Impairment 22%
• Diseases 11%
• Placebo 11%
• Treatment Group 11%
• Tolerability 11%
• Papilledema 11%
• Intracranial Hypertension 11%